FDA Investigator Maura Rooney

Maura Rooney has conducted inspections on 65 sites in 4 countries as of 07 Jul 2021. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
65
Last Inspection Date:
07 Jul 2021
Investigator Role:
FDA Investigator
Redica ID:
100001384
Countries of Inspections:
China, United States of America, Korea (Republic of), Japan
FDA Investigators that have inspected at least one site in common with Maura Rooney:
Abby E Pelletier, Alan M Stevens, Alan R Condon, Allison A Rodriguez, Althea A Williams, Amber G Wardwell, Andrew M Barlow, Arie C Menachem, Ashley M Whitehurst, Barbara G Swan, Brenda P King, Camerson E Moore, Carla C Cummins, Carla C Tuite, Constance Desimone, Cynthia L Gorveatt, Darin S Wiegers, David J Feria, David P Vanhouten, Dawn M Braswell, Diane C Thibodeau, Diane M Biron, Dien N Nguyen, Dolores Harper, Dorothy W Lee, Dr. Gang Wang, PhD, Edward J Janik, Elizabeth B Griffin, Ellen P Madigan, Eric C Schmitt, Frank P Hurst, Garry H Stewart, Gary J Hagan, George T Allen, Jr, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James H Tanner, James P Finn, James W Whitney, Janete F Guardia, Jason A Rossi, Jayaleka J Amarasinghe, Jeffrey J Thibodeau, John A Sciacchitano, John P Mistler, Jonathan B Lewis, Jonathan G Matrisciano, Juanita Banuelos, Justine M Corson, Karen Mcnabb Noon, Katarzyna Plona, Kathleen M Curry, Kayla R Huffman, Kent A Conforti, Kristina J Donohue, Lauren M Lawrance, Lauren M Mclaughlin, Laurie B Frazier, LCDR Debra Emerson, Leonard H Lavi, Linda A Gregory Duty, Lori J Silverstein, Lori M Newman, Lori S Lawless, Lynne M Dwyer, Marcia M Laughrey, Margaret M Doherty, Margaret M Sands, Mark R Mcclain, Mary Jeanet Mcgarry, Maryam Tabatabaie, Matthew B Hazelett, Maya M Davis, Megan A Haggerty, Michael G Mayfield, Michael P Anthony, Michael P Sweeney, Michael Serrano, Mutahar S Shamsi, Nabil Nakhoul, Pamela N Agaba, Paul E Stein, Paul M Kawamoto, Paul P Geraci, Perry H Gambrell, Philip H Lafleur, Preston M Lee, Qiao Y Bobo, Ramon E Martinez, Rebecca B Welch, Ronald A Stokes, Rory K Geyer, Ryan J Mcgowan, Sandra P White, Sara M Onyango, Scott B Laufenberg, Seth A Mailhot, Shawn M Bogdan, Sherry M Nisson, Stacey S Degarmo, Stephen C King, Stephen C Smith, Stephen D Eich, Stephen R Souza, Steven M Ferrara, Sunita Pandey, Susanne M Richardson, MS RAC, Suzanne M Healy, Tamara S Rosbury, Tanya R Syffrard, Terry C Kimball, Todd J Maushart, Tomika L Crafter, Xiaojun Yan

Maura Rooney's Documents

Publish Date Document Type Title
October, 2013 FDA 483 Atrium Medical Corporation - Form 483, 2013-10-01
March, 2013 FDA 483 Hemedex, Inc. - Form 483, 2013-03-14
March, 2020 FDA 483 Concert Medical, LLC - Form 483, 2020-03-05
April, 2011 FDA 483 Belmont Instrument Corporation - Form 483, 2011-04-27
July, 2021 EIR CooperSurgical, Inc. - EIR, 2021-08-12
July, 2021 FDA 483 CooperSurgical, Inc. - Form 483, 2021-07-15
March, 2013 FDA 483 Hightech American Industrial Laboratories, Inc. - Form 483, 2013-03-22
February, 2013 FDA 483 Fresenius Medical Care Holdings, Inc. - Form 483, 2013-02-21
October, 2012 FDA 483 The Judge Rotenberg Educational Center, Inc. - Form 483, 2012-10-17
January, 2012 FDA 483 Nova Biomedical Corporation - Form 483, 2012-01-13
November, 2011 FDA 483 Fresenius Medical Care Holdings, Inc. - Form 483, 2011-10-28
September, 2010 FDA 483 Carrot Medical, LLC - Form 483, 2010-09-29
December, 2011 FDA 483 Insulet Corporation - Form 483, 2011-12-19
November, 2012 FDA 483 Anika Therapeutics Inc - Form 483, 2012-11-14
July, 2011 FDA 483 Medical Information Technology, Inc. - Form 483, 2011-07-08
April, 2012 FDA 483 Cynosure, Inc. - Form 483, 2012-04-25
May, 2012 FDA 483 YANG MING INDUSTRY (ZHEJIANG) LIMITED - Form 483, 2012-05-24
December, 2009 FDA 483 Anika Therapeutics, Incorporated - Form 483, 2009-12-16
March, 2012 FDA 483 Abbott Laboratories - Form 483, 2012-03-16
April, 2012 FDA 483 Direx Systems Corp. - Form 483, 2012-04-04
May, 2013 FDA 483 Dongguan Mars Medical Products Co., Ltd. - Form 483, 2013-05-30
September, 2012 FDA 483 Brain Research, Inc. - Form 483, 2012-09-07
December, 2012 FDA 483 Primo Medical Group, Inc - Form 483, 2012-12-10
April, 2013 FDA 483 Draeger Medical Systems, Inc. - Form 483, 2013-04-12

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more